20192024: Highbridge Multi-Strategy Master Fund, L.P.; Nalpropion Pharmaceuticals, Inc.

Date:
Transaction Number:

20192024

Acquiring Party:

Highbridge Multi-Strategy Master Fund, L.P.

Acquired Party:

Nalpropion Pharmaceuticals, Inc.

Granting Status:

Granted

Acquired Entities

  • Nalpropion Pharmaceuticals, Inc.